Patents Assigned to PROLONG PHARMACEUTICALS, INC.
  • Modified erythropoietin
    Patent number: 8765924
    Abstract: This invention relates to novel protein conjugates, in particular, to novel pegylated proteins, and their methods of making and use. One aspect of the present invention relates to pegylated-erythropoietin having greater clinical efficacy and stability during shipment and storage than current erythropoietin formulations.
    Type: Grant
    Filed: July 16, 2007
    Date of Patent: July 1, 2014
    Assignee: Prolong Pharmaceuticals, Inc.
    Inventors: Abraham Abuchowski, Lihsyng Stanford Lee
  • MODIFIED ERYTHROPOIETIN
    Publication number: 20100184655
    Abstract: This invention relates to novel protein conjugates, in particular, to novel pegylated proteins, and their methods of making and use. One aspect of the present invention relates to pegylated-erythropoietin having greater clinical efficacy and stability during shipment and storage than current erythropoietin formulations.
    Type: Application
    Filed: July 16, 2007
    Publication date: July 22, 2010
    Applicant: PROLONG PHARMACEUTICALS, INC.
    Inventors: Abraham Abuchowski, Lihsyng Stanford Lee